Putnam Investments LLC Veracyte, Inc. Transaction History

Putnam Investments LLC

$73 Billion
Q4 2023

A detailed history of Putnam Investments LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 159,793 shares of VCYT stock, worth $5.63 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

159,793

Previous 152,840 4.55%

Holding current value

$5.63 Million

Previous $3.41 Million 28.81%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$19.72 - $28.68 $137,113 - $199,412	6,953 Added 4.55%	159,793 $4.4 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $42,427 - $56,848	-1,900 Reduced 1.23%	152,840 $3.41 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $161,454 - $207,903	7,703 Added 5.24%	154,740 $3.94 Million
Q1 2023 May 22, 2023	SELL	$20.58 - $27.89 $749,235 - $1.02 Million	-36,406 Reduced 19.85%	147,037 $3.28 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $211,278 - $413,172	-13,800 Reduced 7.0%	183,443 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$16.58 - $27.9 $348,246 - $586,011	21,004 Added 11.92%	197,243 $3.28 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $2.72 Million - $5.2 Million	176,239 New	176,239 $3.51 Million
Q1 2022 May 16, 2022	SELL	$21.94 - $42.51 $2.32 Million - $4.5 Million	-105,916 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $222,422 - $331,507	6,163 Added 6.18%	105,916 $4.36 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $890 - $1,324	-25 Reduced 0.03%	99,753 $4.63 Million
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $103,596 - $178,069	-3,145 Reduced 3.06%	99,778 $3.99 Million
Q1 2021 May 17, 2021	SELL	$44.47 - $81.38 $172,677 - $315,998	-3,883 Reduced 3.64%	102,923 $5.53 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $25,244 - $48,080	-777 Reduced 0.72%	106,806 $5.23 Million
Q3 2020 Nov 16, 2020	SELL	$26.73 - $35.67 $5,078 - $6,777	-190 Reduced 0.18%	107,583 $3.5 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $82,540 - $119,045	4,235 Added 4.09%	107,773 $2.79 Million
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $5,242 - $9,805	-325 Reduced 0.31%	103,538 $2.52 Million
Q4 2019 Feb 14, 2020	BUY	$20.78 - $29.99 $76,366 - $110,213	3,675 Added 3.67%	103,863 $2.9 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $2.39 Million - $3.1 Million	100,188 New	100,188 $2.4 Million

Others Institutions Holding VCYT

# of Institutions

254

Shares Held

82.1M

Call Options Held

42.3K

Put Options Held

18.2K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.52B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Account

Putnam Investments LLC Veracyte, Inc. Transaction History